Abstract:Introduction Bone marrow mesenchymal stem cells (BMSCs) possess low immunogenicity and immunosuppression as an allograft, can differentiate into insulin-producing cells (IPCs) by in vitro induction, and may be a valuable cell source to regenerate pancreatic islets. However, the very low differentiation efficiency of BMSCs towards IPCs under adherent induction has thus far hindered the clinical exploitation of these cells. The aim of this study is to explore a new way to efficiently induce BMSCs into IPCs and lay the groundwork for their clinical exploitation. Methods In comparison with adherent induction, BMSCs of human first-trimester abortus (hfBMSCs) under a nonadherent state were induced towards IPCs in noncoated plastic dishes using a three-stage induction procedure developed by the authors. Induction effects were evaluated by statistics of the cell clustering rate of induced cells, and ultrastructural observation, dithizone staining, quantitative polymerase chain reaction and immunofluorescence assay, insulin and c-peptide release under glucose stimulus of cell clusters, as well as transplantation test of the cell clusters in diabetic model mice. Results With (6.175 ± 0.263) × 10 5 cells in 508.5 ± 24.5 cell clusters, (3.303 ± 0.331) × 10 5 single cells and (9.478 ± 0.208) × 10 5 total cell count on average, 65.08 ± 2.98% hfBMSCs differentiated into pancreatic islet-like cell clusters after nonadherent induction. With (3.993 ± 0.344) × 10 5 cells in 332.3 ± 41.6 cell clusters, (5.437 ± 0.434) × 10 5 single cells and (9.430 ± 0.340) × 10 5 total cell count on average, 42.37 ± 3.70% hfBMSCs differentiated into pancreatic islet-like cell clusters after adherent induction ( P < 0.01, n = 10). The former is significantly higher than the latter. Calculated according to the cell clustering rate and IPC percentage in the cell clusters, 29.80 ± 3.95% hfBMSCs differentiated into IPCs after nonadherent induction and 18.40 ± 2.08% hfBMSCs differentiated into IPCs after adherent induction ( P < 0.01, n = 10), the former significantly higher than the latter. The cell clusters expressed a broad gene profile related to pancreatic islet cells, released insulin and c-peptide in a glucose concentration-dependent manner, and normalized hyperglycemia of streptozocin-induced mice for at least 80 days following xenograft. Blood glucose of grafted mice rose again after their graft removed. A series of examination of the grafts showed that transplanted cells produced human insulin in recipients. Conclusions Our studies demonstrate that nonadherent induction can greatly promote BMSCs to form pancreatic islet-like cell clusters, thereby improving the differentiation efficiency of BMSCs towards IPCs.

A hybrid construct of decellularized matrix and fibrin for differentiating adipose stem cells into insulin-producing cells, an optimized in vitro assessment

Preclinical Optimization of a Shelf-Ready, Injectable, Human-Derived, Decellularized Allograft Adipose Matrix.

Acquisition of durable insulin-producing cells from human adipose tissue-derived mesenchymal stem cells as a foundation for cell- based therapy of diabetes mellitus

In vitro Differentiation of Human Adipose Tissue-Derived Stem Cells into Islet-Like Clusters Promoted by Islet Neogenesis-Associated Protein Pentadecapeptide.

The generation of islet-like insulin-producing cells from Wharton's jelly-derived mesenchymal stem cells on the PES/fish gelatin scaffold

Injectable and Self-Adaptive Gel Scaffold Based on Heparin Microspheres for Adipogenesis of Human Adipose-Derived Stem Cells.

Insulin-Producing Cells Differentiated from Human Bone Marrow Mesenchymal Stem Cells in Vitro Ameliorate Streptozotocin-Induced Diabetic Hyperglycemia

Differentiation of Wharton's Jelly-derived mesenchymal stem cells into insulin-producing beta cells with the enhanced functional level on electrospun PRP-PVP-PCL/PCL fiber scaffold

Enhanced differentiation of human amniotic fluid-derived stem cells into insulin-producing cells in vitro.

In Vitro Differentiation of Human Adipose Tissue-Derived Stromal Cells into Insulin-Producing Cells

Insulin-producing Cells from Human Adipose Tissue-Derived Mesenchymal Stem Cells Detected by Atomic Force Microscope

Enhancing differentiation and functionality of insulin-producing cells derived from iPSCs using esterified collagen hydrogel for cell therapy in diabetes mellitus

Circulation perfusion culture of insulin-producing cells using rat decellularized pancreatic scaffolds

Morphological Characteristics and Identification of Islet-Like Cells Derived from Rat Adipose-Derived Stem Cells Cocultured with Pancreas Adult Stem Cells

Interpenetrating Network of Alginate–Human Adipose Extracellular Matrix Hydrogel for Islet Cells Encapsulation

Covalently Crosslinked Chitosan-Poly(ethylene Glycol) Hybrid Hydrogels to Deliver Insulin for Adipose-Derived Stem Cells Encapsulation

Induction differentiation of rabbit adipose‑derived stromal cells into insulin‑producing cells in vitro

Under a nonadherent state, bone marrow mesenchymal stem cells can be efficiently induced into functional islet-like cell clusters to normalize hyperglycemia in mice: a control study

Decellularized human pancreatic extracellular matrix-based physiomimetic microenvironment for human islet culture

Hybrid adipogenic implants from adipose stem cells for soft tissue reconstruction in vivo

Differentiation of human adipose-derived stem cells into islet beta-like cells in vitro